Loading...
The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer
OBJECTIVE: Homologous recombination (HR)-proficient ovarian tumors have poorer clinical outcomes and show resistance to poly ADP ribose polymerase inhibitors (PARPi). A subset of HR-proficient ovarian tumors show amplification in bromodomain and extra-terminal (BET) genes such as BRD4. We aimed to t...
Na minha lista:
| Udgivet i: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5986599/ https://ncbi.nlm.nih.gov/pubmed/29567272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.03.049 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|